Nesiritide: a review of its use in acute decompensated heart failure
GM Keating, KL Goa - Drugs, 2003 - Springer
GM Keating, KL Goa
Drugs, 2003•SpringerNesiritide (Natrecor® 1) is arecombinant form of human B-type (brain) natriuretic peptide
that has beneficial vasodilatory, natriuretic, diuretic and neurohormonal effects. The drug is
administered intravenously for the management of patients with decompensated congestive
heart failure (CHF).
that has beneficial vasodilatory, natriuretic, diuretic and neurohormonal effects. The drug is
administered intravenously for the management of patients with decompensated congestive
heart failure (CHF).
Summary
Nesiritide (Natrecor® 1) is arecombinant form of human B-type (brain) natriuretic peptide that has beneficial vasodilatory, natriuretic, diuretic and neurohormonal effects. The drug is administered intravenously for the management of patients with decompensated congestive heart failure (CHF).
Springer